Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Longfa Xu

3PUBLICATIONS

14CO-AUTHORS

Nanotoxicology, health and safetyMolecular targetsInfectious diseases

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Oct 18, 2024

Broadly therapeutic antibody provides cross-serotype protection against enteroviruses via Fc effector functions and by mimicking SCARB2.

Rui Zhu, Yuanyuan Wu, Yang Huang

|Feb 09, 2019

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge.

Ruixiao Du, Qunying Mao, Yalin Hu

|Sep 27, 2018

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10.

Rui Zhu, Longfa Xu, Qingbing Zheng

Pageof 1

Frequent Collaborators

3 joint publications

Tong Cheng

2 joint publications

Rui Zhu

2 joint publications

Qingbing Zheng

2 joint publications

Shaowei Li

2 joint publications

Ningshao Xia

1 joint publications

Yanxiang Cui

1 joint publications

Hai Yu

1 joint publications

Timothy S Baker

1 joint publications

Xiaodong Yan

1 joint publications

Z Hong Zhou

Frequent Collaborators

3 joint publications

Tong Cheng

2 joint publications

Rui Zhu

2 joint publications

Qingbing Zheng

2 joint publications

Shaowei Li

Top Related Videos

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on : Feb 23, 2018

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on : Jul 15, 2019

See more related videos

Top Related Videos

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on : Feb 23, 2018

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on : Jul 15, 2019

See more related videos